Aromatase Inhibitors: Did you decide to go on them or not?
Nanaloves: I’m about to start arimidex and just feel that the contraindications , bone issues etc. are overwhelming. I’m 70 years old, dodged a bullet I feel with zero stage DCIS but the follow up is pretty much no different then if it was more aggressive. I’ve just done 33 treatments of radiation and now they advise arimidex as a preventative. I’m not sure with the beginnings of arthritis and lower back. sensitivity already that I should take it. Anyone not take it and not have a recurrence within the 5 years.
Interested in more discussions like this? Go to the Breast Cancer Support Group.
@slfisher1976 I didn't remember what that classification meant.
In stage 1A breast cancer, the tumor measures up to 2 centimeters, but there’s no lymph node involvement. With stage 1B breast cancer, the tumor is less than 2 centimeters, but there are small clusters of cancer cells in nearby lymph nodes.
and
Stage 1B: Cancer between 0.2 mm and 2 mm is found in the lymph nodes (the breast tumor can’t be detected or is smaller than 20 mm).
The NX means the lymph nodes cannot be evaluated.
Not sure what it means if the nodes cannot be evaluated but you are 1b!
No offense, but it seems a lot of oncologists are cheerful and reassuring.....
My response is simple… you don’t need to know what you don’t need to know. Personally, three weeks out from a lumpectomy, margins clear, staged 1bNX, I’m looking forward to my radiation “rehearsal” and then (I hope) an accelerated partial breast course of treatment. My surgical teams calls my pathology report “fantastic,” and for now, that’s all I need to know.
The aromatase inhibitors stop the production of estrogen. Estrogen helps support bone renewal. Pre-menopausal women are said to have an 'estrogen shield' protecting their bones to some extent. That is lost (though not 100%) with menopause and is one reason that many women take 'hormone replacement therapy' after menopause. Estrogen does a lot of other things as well. I'm not sanguine that it's other functions are getting due attention. Loss of bone density is so obvious that oncologists have to address it for patients on anti-estrogen therapy.
I personally don't use these sites. Their results are very different from my genomic tests. I am 7 years out from diagnosis anyway!
Yes that is the correct site. Oncologist use this site often. Anyone can use ONCOassist app. Go to Adjuvant tools and then go to breast cancer. Their results are pretty much the same as Predict.
I can only say the post-surgery biopsy of the tumor excised from me was described as DCIS-invasive. I agree it sounds like a contradiction in terms so maybe it's a sub-category that identifies the tumor location (and type, DCIS being the most common type of first-event breast cancer) and the fact that 'invasive' was the variable that made it a Stage 1A. Otherwise the size of the tumor would have made it a Stage 0. It was good news that it was so small with no lymph node involvement. Though I'd far rather there wasn't anything there to be found by a mammo in the first place...
It's very encouraging to read how the aromatase inhibitor made such a difference!
In situ is Non-infiltrating , Non-invasive. If cancer cells are outside the ducts then by definition it’s not ‘in-situ’. I don’t believe cancer can be a ‘little’ bit invasive. I know we want to believe that but using incorrect diagnosis is not fair to patient. I k ow things aren’t clear cut but how far from the duct do the cancers have to be to be considered stage 1A? Just askin’ because this type of information gets generated and picked up by others & then becomes the way of thinking. It’s not helping the patient by sugar coating & I k ow we all want to hear the lesser diagnosis. God Bless you all.
Your description is so right on! My primary doctor likened AI therapy and cancer treatment in general to a game of Jenga. Trying to balance the tower,removing and adding pieces and hoping it all doesn’t collapse.
@orsejr is this the Predict you were referring to?
https://breast.predict.nhs.uk/tool
I was looking at a different Predict tool! ONCOassist does say it is for professionals but maybe we can use it. I haven't downloaded it.
The Predict tool gives a much worse diagnosis for me than Oncotype, Breast Cancer Index or Prosigna Assay, which are all genomic tests using actual specimens from pathology. The Predict tool also shows marginal benefit from AI's, which also differs from the Oncotype but not the Breast Cancer Index.
The Predict tool goes by pathology results, which may be very different from the results from genomic tests. For instance, 30% of grade 3's have low Oncotypes.
I am glad I never look at the Predict tool. I have made it 7 years so far and an 83% chance of survival over 10 years, as the Predict tells me, would have caused a lot of anxiety.